tiprankstipranks
Trending News
More News >
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Advertisement

Enanta Pharmaceuticals (ENTA) Revenue

Compare
178 Followers

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had a revenue of 14.93M in the quarter ending Jun 30, 2025, with -11.99%. This bring the company's revenue in the last twelve months to 64.46M, Increased -3.20%. In the fiscal year ending Dec 31, 2024, Enanta Pharmaceuticals had annual revenue of 67.64M with -14.61% growth.
Revenue (ttm)
64.46M
Revenue Growth
-9.94%
P/S Ratio
2.73
Revenue/Employee
$516,298
Employees
131
Market Cap
$184.92M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
67.64M-11.57M-14.61%
Dec 31, 2023
79.20M-6.96M-8.07%
Dec 31, 2022
86.16M-10.91M-11.24%
Dec 31, 2021
97.07M-25.40M-20.74%
Dec 31, 2020
122.47M-82.72M-40.31%
Dec 31, 2019
205.20M-1.43M-0.69%
Dec 31, 2018
206.63M103.81M+100.97%
Dec 31, 2017
102.81M14.55M+16.48%
Dec 31, 2016
88.27M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis